ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 742.00
-7.50 (-1.00%)
At close: Dec 5, 2025
ChemoMetec Market Cap
ChemoMetec has a market cap or net worth of 12.91 billion as of December 5, 2025. Its market cap has increased by 71.52% in one year.
Market Cap
12.91B
Enterprise Value
12.58B
Revenue
495.57M
Ranking
n/a
PE Ratio
69.28
Stock Price
742.00
Market Cap Chart
Since December 18, 2006, ChemoMetec's market cap has increased from 374.48M to 12.91B, an increase of 3,348.12%. That is a compound annual growth rate of 20.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 12.91B | 52.61% |
| Dec 30, 2024 | 8.46B | 25.31% |
| Dec 29, 2023 | 6.75B | -43.81% |
| Dec 30, 2022 | 12.02B | -17.11% |
| Dec 30, 2021 | 14.50B | 44.12% |
| Dec 30, 2020 | 10.06B | 211.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.36T |
| Coloplast | 131.88B |
| Genmab | 127.02B |
| ALK-Abelló | 50.74B |
| Demant | 45.41B |
| H. Lundbeck | 42.14B |
| Zealand Pharma | 35.55B |
| Ambu A/S | 23.18B |